Recordati Industria Chimica e Farmaceutica S.p.A.

Milan Stock Exchange REC.MI

Recordati Industria Chimica e Farmaceutica S.p.A. Gross Profit Margin for the year ending December 31, 2023: 68.32%

Recordati Industria Chimica e Farmaceutica S.p.A. Gross Profit Margin is 68.32% for the year ending December 31, 2023, a -1.59% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
  • Recordati Industria Chimica e Farmaceutica S.p.A. Gross Profit Margin for the year ending December 31, 2022 was 69.42%, a -4.81% change year over year.
  • Recordati Industria Chimica e Farmaceutica S.p.A. Gross Profit Margin for the year ending December 31, 2021 was 72.93%, a 1.40% change year over year.
  • Recordati Industria Chimica e Farmaceutica S.p.A. Gross Profit Margin for the year ending December 31, 2020 was 71.92%, a 1.99% change year over year.
  • Recordati Industria Chimica e Farmaceutica S.p.A. Gross Profit Margin for the year ending December 31, 2019 was 70.52%, a -0.33% change year over year.
Key data
Date Gross Profit Margin Operating Income Margin EBT Margin Net Income Margin
Market news
Loading...
Milan Stock Exchange: REC.MI

Recordati Industria Chimica e Farmaceutica S.p.A.

CEO Dr. Robert Koremans M.D.
IPO Date March 28, 1995
Location Italy
Headquarters 1, Via Matteo Civitali
Employees 4,450
Sector Health Care
Industries
Description

Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.

Similar companies

CPR.MI

Davide Campari-Milano N.V.

USD 5.59

-2.10%

AMP.MI

Amplifon S.p.A.

USD 26.82

1.34%

BRE.MI

Brembo S.p.A.

USD 8.91

-0.66%

DIA.MI

DiaSorin S.p.A.

USD 103.47

-0.44%

PRY.MI

Prysmian S.p.A.

USD 65.92

0.76%

StockViz Staff

January 15, 2025

Any question? Send us an email